Literature DB >> 1545255

Severe limitation in mouth opening following transtemporal neurosurgical procedures: diagnosis, treatment, and prevention.

D W Nitzan1, B Azaz, S Constantini.   

Abstract

Five new patients and six previously described patients with severe limitation in maximum mouth opening following transtemporal neurosurgical procedures are described. Six patients underwent an operation for epidural hematoma and three for skull-base meningloma; two were treated with a pterional craniotomy for an aneurysm. Limited maximum mouth opening in these circumstances is caused by temporal muscle scarring and shortening. Aggressive physiotherapy is potentially beneficial if started early. If, however, diagnosis is delayed, the efficacy of physiotherapy declines, and surgical treatments such as temporal muscle detachment and coronoidectomy are fully indicated. The differential diagnosis, prevention, and treatment of limited maximum mouth opening following neurosurgical procedures are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1545255     DOI: 10.3171/jns.1992.76.4.0623

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  The transzygomatic approach: a long-term clinical review.

Authors:  S Honeybul; G Neil-Dwyer; D A Lang; B T Evans; P D Lees
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Airway management in a patient with pseudoankylosis of the mandible following frontotemporal craniotomy.

Authors:  M Kawaguchi; T Sakamoto; H Ohnishi; M Takaoka; J Karasawa
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

Review 3.  Airway management in neuroanaesthesia.

Authors:  B F Spiekermann; D J Stone; D L Bogdonoff; T A Yemen
Journal:  Can J Anaesth       Date:  1996-08       Impact factor: 5.063

4.  Unruptured Supraclinoid Internal Carotid Artery Aneurysm Surgery : Superciliary Keyhole Approach versus Pterional Approach.

Authors:  Donguk Shin; Jaechan Park
Journal:  J Korean Neurosurg Soc       Date:  2012-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.